Autoimmunity in Metabolic Diseases like Type 1 Diabetes

Autoimmune processes are a key factor in the development of metabolic diseases such as Type 1 Diabetes (T1D). In T1D, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas, leading to their destruction. This immune response is often triggered by a combination of genetic factors and environmental influences, such as viral infections or changes in the gut microbiome. Autoantibodies like insulin autoantibodies (IAA) and glutamic acid decarboxylase antibodies (GADA) can be detected long before T1D symptoms appear, signaling the onset of autoimmunity. Over time, the gradual loss of beta cells impairs insulin production, resulting in difficulty controlling blood sugar. Understanding these autoimmune mechanisms can help develop treatments to preserve beta cells and delay disease onset.